NDC 62207-502 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62207-502
- Package NDCs from labels
- 62207-502-02, 62207-502-03, 62207-502-04, 62207-502-11, 62207-502-12, 62207-502-13
- Manufacturer
- Granules India Limited
- Effective date
- 2025-10-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Granules India Limited | Granules India Limited | 2025-10-24 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62207-502-02 | Methocarbamol | 25 kg in 1 BAG | POWDER | 25 | 13 | |
| 62207-502-03 | Methocarbamol | 40 kg in 1 BAG | POWDER | 40 | 13 | |
| 62207-502-04 | Methocarbamol | 50 kg in 1 BAG | POWDER | 50 | 13 | |
| 62207-502-11 | Methocarbamol | 25 kg in 1 BAG | POWDER | 25 | 13 | |
| 62207-502-12 | Methocarbamol | 40 kg in 1 BAG | POWDER | 40 | 13 | |
| 62207-502-13 | Methocarbamol | 50 kg in 1 BAG | POWDER | 50 | 13 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | Advanced Rx Pharmacy of Tennessee, LLC | c9600cc9-7e27-6e19-e053-2995a90ab024 | 2024-12-31 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx Pharmacy of Tennessee, LLC | f4e98f9f-b20b-8608-e053-2a95a90aa6b0 | 2024-12-31 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx Pharmacy of Tennessee, LLC | f6567e04-12f0-fa79-e053-2995a90a9a0e | 2024-12-31 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 8c18ffef-b2c5-4af2-af66-e22c168e7680 | 2024-12-24 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Key Therapeutics | a88a6c84-b55a-4b6b-ac01-554079f6e304 | 2024-10-09 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Key Therapeutics | cf931001-95bd-4900-98d5-f5ef54b49d99 | 2024-10-09 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Fresenius Kabi USA, LLC | bdf17640-221c-4c80-b48c-101daaece1d6 | 2024-08-22 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 3f47c39b-9373-454f-9a4e-ba6dd65dd7a4 | 2024-08-20 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | add9e47f-11ac-e10d-bfc2-b9c52aa08fa5 | 2024-08-20 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals,Inc. | 9d6024b2-ee1a-3a79-e053-2a95a90a1bf4 | 2024-08-14 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals, Inc. | 3e89a426-c741-2f44-e054-00144ff8d46c | 2024-08-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NCS HealthCare of KY, LLC dba Vangard Labs | 32ea8117-4a35-4e2c-93bc-866544b2c3be | 2024-08-12 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 47d8f1c7-8395-48e0-ac6f-d35dadfb7a50 | 2024-08-01 | Warnings, Adverse reactions | 125OD7737X |
| Tanlor | METHOCARBAMOL | Forte Bio-Pharma | 1dd5f7fd-7b3b-8669-e063-6394a90abe95 | 2024-07-22 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals, Inc. | 1c368c79-ac60-bfa7-e063-6394a90a9ff7 | 2024-07-01 | Warnings, Adverse reactions | 125OD7737X |
| methocarbamol | METHOCARBAMOL | Slate Run Pharmaceuticals, LLC | bc16295e-f3aa-4ed5-9fd6-ac4c750e0bba | 2024-06-24 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 5a9b1104-4c9a-4c8c-9e24-719a7b3a89d7 | 2024-06-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Pharmasource Meds, LLC | f43a9389-c641-ce49-e053-2a95a90a537f | 2024-05-28 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 1880efb2-b97e-1e4d-e063-6294a90ab3e3 | 2024-05-18 | Warnings, Adverse reactions | 125OD7737X |
| ROBAXIN | METHOCARBAMOL | Hikma Pharmaceuticals USA Inc. | 090a3d3d-92c3-4c30-a648-436461f81702 | 2024-04-10 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.